|Application:||Gene expression microarray analysis|
|Number of samples:||30|
|Release date:||May 20 2016|
|Last update date:||Oct 29 2018|
|Dataset link||Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD56+ cells, gene level]|
EDTA blood samples were taken from all patients immediately before first and second fingolimod administration as well as after 3 months of therapy. Total RNA of CD56+ cells positively selected from each blood sample was extracted, labeled and hybridized to high-density Affymetrix HTA 2.0 microarrays to quantify the transcript levels.